Prevention of platelet hyperaggregation during coronary angiography.
The authors previously reported an increase in platelet aggregration in the days after coronary angiography, accompanied at times by worrying cardiovascular disorders (ventricular fibrillation in one case, death in two others). In the present study, ten patients received a platelet antiaggregating drug (ticlopidin) 5 days before their coronary angiography. No significant changes were detected in the test for circulating platelet aggregates (CPA test) in these patients.
D000328:Adult; D017023:Coronary Angiography; D006801:Humans; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D013988:Ticlopidine / Q000627:therapeutic use*
D013988:Ticlopidine